|
US3773919A
(en)
*
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US3632778A
(en)
*
|
1970-06-10 |
1972-01-04 |
Hoffmann La Roche |
Tablets containing l-dopa
|
|
CA1097220A
(en)
*
|
1975-10-10 |
1981-03-10 |
Aaron L. Weiss |
Controlled release tablet
|
|
US4264573A
(en)
*
|
1979-05-21 |
1981-04-28 |
Rowell Laboratories, Inc. |
Pharmaceutical formulation for slow release via controlled surface erosion
|
|
CA1146866A
(en)
*
|
1979-07-05 |
1983-05-24 |
Yamanouchi Pharmaceutical Co. Ltd. |
Process for the production of sustained release pharmaceutical composition of solid medical material
|
|
US4248857A
(en)
*
|
1979-08-09 |
1981-02-03 |
American Home Products Corporation |
Sustained release pharmaceutical compositions
|
|
US4309404A
(en)
*
|
1979-08-09 |
1982-01-05 |
American Home Products Corporation |
Sustained release pharmaceutical compositions
|
|
US4273920A
(en)
*
|
1979-09-12 |
1981-06-16 |
Eli Lilly And Company |
Polymerization process and product
|
|
US4252786A
(en)
*
|
1979-11-16 |
1981-02-24 |
E. R. Squibb & Sons, Inc. |
Controlled release tablet
|
|
US4505890A
(en)
*
|
1983-06-30 |
1985-03-19 |
E. R. Squibb & Sons, Inc. |
Controlled release formulation and method
|
|
DE3448522C2
(de)
*
|
1983-11-11 |
1995-08-24 |
Egyt Gyogyszervegyeszeti Gyar |
Pharmazeutische Präparate, insbesondere Tabletten, mit geregelter beziehungsweise verzögerter Wirkstoffabgabe, sowie Verfahren zur Herstellung derselben
|
|
HU190619B
(en)
|
1983-11-11 |
1986-09-29 |
Bezzegh,Denes,Hu |
Process for producing tablets with controlled dissolution of active ingredients
|
|
US4610870A
(en)
*
|
1984-10-05 |
1986-09-09 |
E. R. Squibb & Sons, Inc. |
Controlled release formulation
|
|
US4666705A
(en)
*
|
1985-06-03 |
1987-05-19 |
E. R. Squibb & Sons, Inc. |
Controlled release formulation
|
|
DE3535536A1
(de)
*
|
1985-10-04 |
1987-04-09 |
Lentia Gmbh |
Verfahren zum gleichzeitigen trocknen und granulieren von extraktstoffen aus enteiweisstem kaelberblut
|
|
US4756911A
(en)
*
|
1986-04-16 |
1988-07-12 |
E. R. Squibb & Sons, Inc. |
Controlled release formulation
|
|
US4738850A
(en)
*
|
1986-05-27 |
1988-04-19 |
E. R. Squibb & Sons, Inc. |
Controlled release formulation and method
|
|
US4772473A
(en)
*
|
1986-06-16 |
1988-09-20 |
Norwich Eaton Pharmaceuticals, Inc. |
Nitrofurantoin dosage form
|
|
US4798725A
(en)
*
|
1986-06-16 |
1989-01-17 |
Norwich Eaton Pharmaceuticals, Inc. |
Sustained release capsule
|
|
US4968508A
(en)
*
|
1987-02-27 |
1990-11-06 |
Eli Lilly And Company |
Sustained release matrix
|
|
US4851226A
(en)
*
|
1987-11-16 |
1989-07-25 |
Mcneil Consumer Products Company |
Chewable medicament tablet containing means for taste masking
|
|
US5702716A
(en)
*
|
1988-10-03 |
1997-12-30 |
Atrix Laboratories, Inc. |
Polymeric compositions useful as controlled release implants
|
|
US5133974A
(en)
*
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
|
US5487897A
(en)
|
1989-07-24 |
1996-01-30 |
Atrix Laboratories, Inc. |
Biodegradable implant precursor
|
|
JPH03145418A
(ja)
*
|
1989-10-27 |
1991-06-20 |
Sumitomo Pharmaceut Co Ltd |
塩基性薬物塩酸塩の徐放性製剤
|
|
AU2605592A
(en)
*
|
1991-10-15 |
1993-04-22 |
Atrix Laboratories, Inc. |
Polymeric compositions useful as controlled release implants
|
|
US5266331A
(en)
*
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
|
KR100355130B1
(ko)
*
|
1992-09-18 |
2003-01-30 |
야마노우치세이야쿠 가부시키가이샤 |
하이드로겔서방성정제
|
|
US20080075781A1
(en)
*
|
1992-11-25 |
2008-03-27 |
Purdue Pharma Lp |
Controlled release oxycodone compositions
|
|
KR0168715B1
(ko)
*
|
1992-11-30 |
1999-01-15 |
밋첼 아이. 커시너 |
맛을 차단하는 약제학적 조성물
|
|
US5431916A
(en)
*
|
1993-04-29 |
1995-07-11 |
The Procter & Gamble Company |
Pharmaceutical compositions and process of manufacture thereof
|
|
US20070275062A1
(en)
*
|
1993-06-18 |
2007-11-29 |
Benjamin Oshlack |
Controlled release oxycodone compositions
|
|
US5681873A
(en)
*
|
1993-10-14 |
1997-10-28 |
Atrix Laboratories, Inc. |
Biodegradable polymeric composition
|
|
DE4406424A1
(de)
*
|
1994-02-28 |
1995-08-31 |
Bayer Ag |
Expandierbare Arzneiformen
|
|
US5840338A
(en)
*
|
1994-07-18 |
1998-11-24 |
Roos; Eric J. |
Loading of biologically active solutes into polymer gels
|
|
US5603955A
(en)
*
|
1994-07-18 |
1997-02-18 |
University Of Cincinnati |
Enhanced loading of solutes into polymer gels
|
|
US8226598B2
(en)
*
|
1999-09-24 |
2012-07-24 |
Tolmar Therapeutics, Inc. |
Coupling syringe system and methods for obtaining a mixed composition
|
|
DE10015479A1
(de)
*
|
2000-03-29 |
2001-10-11 |
Basf Ag |
Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität
|
|
US7985420B2
(en)
*
|
2000-04-28 |
2011-07-26 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin combination drugs
|
|
US7838032B2
(en)
*
|
2000-04-28 |
2010-11-23 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin
|
|
US6955821B2
(en)
*
|
2000-04-28 |
2005-10-18 |
Adams Laboratories, Inc. |
Sustained release formulations of guaifenesin and additional drug ingredients
|
|
US8012504B2
(en)
*
|
2000-04-28 |
2011-09-06 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin combination drugs
|
|
AU2002221412B2
(en)
|
2000-12-05 |
2006-04-13 |
Alexander Macgregor |
Hydrostatic delivery system for controlled delivery of agent
|
|
MY142204A
(en)
*
|
2002-07-25 |
2010-10-29 |
Pharmacia Corp |
Pramipexole once-daily dosage form
|
|
US20050143350A1
(en)
*
|
2003-11-19 |
2005-06-30 |
Seed John C. |
Combination drug therapy to treat obesity
|
|
UA88477C2
(ru)
*
|
2004-08-13 |
2009-10-26 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Композиция пеллеты пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
|
|
ME01316B
(me)
*
|
2004-08-13 |
2013-12-20 |
Boehringer Ingelheim Int |
Formulacija tablete sa produženim oslobađanjem koji sadrži pramipeksol ili njegovu farmaceutski prihvatljivu so
|
|
EP1812025B1
(en)
|
2004-11-02 |
2012-09-05 |
Chr. Hansen A/S |
Stabilized bacteriophage formulations
|
|
KR100753480B1
(ko)
*
|
2006-01-27 |
2007-08-31 |
씨제이 주식회사 |
잘토프로펜 함유 서방성 정제 및 그 제조방법
|
|
US20090098202A1
(en)
*
|
2006-02-10 |
2009-04-16 |
Boehringer Ingelheim International Gmbh |
Extended Release Formulation
|
|
US20090041844A1
(en)
*
|
2006-02-10 |
2009-02-12 |
Boehringer Ingelheim International Gmbh |
Modified Release Formulation
|
|
EP2063862A2
(en)
*
|
2006-09-04 |
2009-06-03 |
Matrix Laboratories Ltd |
Pharmaceutical formulation for use in hiv therapy
|
|
GB2460915B
(en)
*
|
2008-06-16 |
2011-05-25 |
Biovascular Inc |
Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
|
|
GB201506755D0
(en)
|
2015-04-21 |
2015-06-03 |
Reckitt Benckiser Llc |
Novel pharmaceutical formulation
|
|
EP3364955B1
(en)
|
2015-10-09 |
2022-04-20 |
RB Health (US) LLC |
Pharmaceutical formulation
|